(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine

C134H142F6N30O15 — CID 158262008

IUPAC(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine
SMILESCOC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1
InChIInChI=1S/C29H28N6O3.C29H28N6O2.C26H32N6O4.2C25H27F3N6O3/c1-34-19-20(17-32-34)28-18-31-25-10-9-21(15-27(25)33-28)35(22-13-23(36-2)16-24(14-22)37-3)12-6-7-26-29(38-4)8-5-11-30-26;1-20-9-10-30-22(12-20)6-5-11-35(24-13-25(36-3)16-26(14-24)37-4)23-7-8-27-28(15-23)33-29(18-31-27)21-17-32-34(2)19-21;1-34-17-21(33)16-32(20-9-22(35-2)12-23(10-20)36-3)19-5-6-24-25(11-19)30-26(14-28-24)18-13-29-31(15-18)8-4-7-27;2*1-36-19-8-18(9-20(11-19)37-2)34(15-24(35)25(26,27)28)17-4-5-21-22(10-17)32-23(13-30-21)16-12-31-33(14-16)7-3-6-29/h5-11,13-19H,12H2,1-4H3;5-10,12-19H,11H2,1-4H3;5-6,9-15,21,33H,4,7-8,16-17,27H2,1-3H3;2*4-5,8-14,24,35H,3,6-7,15,29H2,1-2H3/b7-6+;6-5+;;;/t;;21-;2*24-/m..110/s1
InChIKeyGHZFHXKOJUAVGV-VJOTYYGYSA-N
MW2526.79 g/mol
LogP21.75
Rot. Bonds49

About (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine

(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine (PubChem CID 158262008) has the molecular formula C134H142F6N30O15 and a molecular weight of 2526.79 g/mol. Its IUPAC name is (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine.

Molecular Properties

Compound Name(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine
PubChem CID158262008
Molecular FormulaC134H142F6N30O15
Molecular Weight2526.79 g/mol
Exact Mass2525.12
IUPAC Name(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine
SMILESCOC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1
InChIInChI=1S/C29H28N6O3.C29H28N6O2.C26H32N6O4.2C25H27F3N6O3/c1-34-19-20(17-32-34)28-18-31-25-10-9-21(15-27(25)33-28)35(22-13-23(36-2)16-24(14-22)37-3)12-6-7-26-29(38-4)8-5-11-30-26;1-20-9-10-30-22(12-20)6-5-11-35(24-13-25(36-3)16-26(14-24)37-4)23-7-8-27-28(15-23)33-29(18-31-27)21-17-32-34(2)19-21;1-34-17-21(33)16-32(20-9-22(35-2)12-23(10-20)36-3)19-5-6-24-25(11-19)30-26(14-28-24)18-13-29-31(15-18)8-4-7-27;2*1-36-19-8-18(9-20(11-19)37-2)34(15-24(35)25(26,27)28)17-4-5-21-22(10-17)32-23(13-30-21)16-12-31-33(14-16)7-3-6-29/h5-11,13-19H,12H2,1-4H3;5-10,12-19H,11H2,1-4H3;5-6,9-15,21,33H,4,7-8,16-17,27H2,1-3H3;2*4-5,8-14,24,35H,3,6-7,15,29H2,1-2H3/b7-6+;6-5+;;;/t;;21-;2*24-/m..110/s1
InChIKeyGHZFHXKOJUAVGV-VJOTYYGYSA-N
XLogP21.75
TPSA509.49 Ų
H-Bond Donors6
H-Bond Acceptors45
Rotatable Bonds49
Heavy Atoms185
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002526.79
LogP ≤ 521.75
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1045

Analyze (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine?
The IUPAC name of (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine (CID 158262008) is (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine.
What is the SMILES notation for (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine?
The canonical SMILES for (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine is COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.
What is the InChIKey of (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine?
The InChIKey is GHZFHXKOJUAVGV-VJOTYYGYSA-N. The full InChI is InChI=1S/C29H28N6O3.C29H28N6O2.C26H32N6O4.2C25H27F3N6O3/c1-34-19-20(17-32-34)28-18-31-25-10-9-21(15-27(25)33-28)35(22-13-23(36-2)16-24(14-22)37-3)12-6-7-26-29(38-4)8-5-11-30-26;1-20-9-10-30-22(12-20)6-5-11-35(24-13-25(36-3)16-26(14-24)37-4)23-7-8-27-28(15-23)33-29(18-31-27)21-17-32-34(2)19-21;1-34-17-21(33)16-32(20-9-22(35-2)12-23(10-20)36-3)19-5-6-24-25(11-19)30-26(14-28-24)18-13-29-31(15-18)8-4-7-27;2*1-36-19-8-18(9-20(11-19)37-2)34(15-24(35)25(26,27)28)17-4-5-21-22(10-17)32-23(13-30-21)16-12-31-33(14-16)7-3-6-29/h5-11,13-19H,12H2,1-4H3;5-10,12-19H,11H2,1-4H3;5-6,9-15,21,33H,4,7-8,16-17,27H2,1-3H3;2*4-5,8-14,24,35H,3,6-7,15,29H2,1-2H3/b7-6+;6-5+;;;/t;;21-;2*24-/m..110/s1.
What are the key properties of (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine?
(2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine has a molecular weight of 2526.79 g/mol, XLogP of 21.75, 49 rotatable bonds, 6 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-1-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-3-methoxypropan-2-ol;(2S)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;(2R)-3-(N-[3-[1-(3-aminopropyl)pyrazol-4-yl]quinoxalin-6-yl]-3,5-dimethoxyanilino)-1,1,1-trifluoropropan-2-ol;N-(3,5-dimethoxyphenyl)-N-[(E)-3-(3-methoxy-2-pyridinyl)prop-2-enyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[(E)-3-(4-methyl-2-pyridinyl)prop-2-enyl]quinoxalin-6-amine is sourced from PubChem (CID 158262008), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).